Company profile
LabGenius Therapeutics
Combining human and machine intelligence to discover the next generation of therapeutic antibodies.
- Industry
- Biotechnology Research
- Employees
- 72
- Headquarters
- London, UK
- Founded
- 2012
- LinkedIn followers
- 18,112
- Office locations
- 1
LabGenius Therapeutics company summary
LabGenius Therapeutics is a company in the Biotechnology Research industry, headquartered in London, UK, founded in 2012. On LinkedIn the company has around 72 employees and 18,112 followers. Its listed specialties include Medical, Health, DNA Libraries.
What technology does LabGenius Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About LabGenius Therapeutics
LabGenius Therapeutics ("LabGenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVA™, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. While EVA™ is both modality and format-agnostic, LabGenius' internal pipeline is focussed on the development of selectivity-enhanced antibodies for the treatment of solid tumours. The company's novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.
Specialties
Where is LabGenius Therapeutics located?
LabGenius Therapeutics lists 1 location.
Compare companies similar to LabGenius Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
LabGenius Therapeutics labgeniustx.com | Biotechnology Research | 72 | 2012 | London, UK |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about LabGenius Therapeutics
What does LabGenius Therapeutics do?
LabGenius Therapeutics ("LabGenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVA™, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. While EVA™ is both modality and format-agnostic, LabGenius' internal pipeline is focussed on the development of selectivity-enhanced antibodies for the treatment of solid tumours. The company's novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.
How many employees does LabGenius Therapeutics have?
LabGenius Therapeutics has around 72 employees on LinkedIn.
Where is LabGenius Therapeutics headquartered?
LabGenius Therapeutics is headquartered in London, UK.
When was LabGenius Therapeutics founded?
LabGenius Therapeutics was founded in 2012.
Build a lead list from companies like LabGenius Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.